Results for tag: "Hyperinsulinemia Drug"

The Hyperinsulinemia Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. Hyperinsulinemia is a condition in which the body produces too much insulin, leading to a variety of health issues. Hyperinsulinemia drugs are used to treat this condition, and can be divided into two categories: oral medications and injectable medications. Oral medications are taken orally and work by blocking the release of glucose from the liver, while injectable medications are injected directly into the bloodstream and work by blocking the action of insulin. The Hyperinsulinemia Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Pfizer. Show Less Read more